Indications of Peptide Receptor Radionuclide Therapy (PRRT) in Gastroenteropancreatic and Pulmonary Neuroendocrine Tumors: An Updated Review

Indications of Peptide Receptor Radionuclide Therapy (PRRT) in Gastroenteropancreatic and Pulmonary Neuroendocrine Tumors: An Updated Review

Radionuclide therapy for neuroendocrine tumors is a form of systemic radiotherapy that allows the administration of targeted radionuclides into tumor cells that express a large quantity of somatostatin receptors. The two most commonly used radio-peptides for radionuclide therapy in neuroendocrine tu...

Full description

Bibliographic Details
Main Authors: Baptiste Camus, Anne-Ségolène Cottereau, Lola-Jade Palmieri, Solène Dermine, Florence Tenenbaum, Catherine Brezault, Romain Coriat
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Journal of Clinical Medicine
Subjects:
neuroendocrine tumors
neoplasm metastasis
PRRT
peptide receptor radionuclide therapy
gastroenteropancreatic tumor
pulmonary tumor
Online Access:https://www.mdpi.com/2077-0383/10/6/1267

Internet

https://www.mdpi.com/2077-0383/10/6/1267

Similar Items